133 related articles for article (PubMed ID: 27231952)
1. Diagnostic significance of circulating multiple miRNAs in breast cancer: a systematic review and meta-analysis.
Xie S; Wang Y; Liu H; Wang M; Yu H; Qiao Y; Li F; Xie X; Zhang J
Biomark Med; 2016 Jun; 10(6):661-74. PubMed ID: 27231952
[TBL] [Abstract][Full Text] [Related]
2. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
Cui Z; Lin D; Song W; Chen M; Li D
Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
[TBL] [Abstract][Full Text] [Related]
4. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
Xu SL; Tian YY; Zhou Y; Liu LQ
Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of circulating microRNAs for nasopharyngeal cancer: a systematic review and meta-analysis.
Wang Z; Chen W; Zhang Y; Xu L; Wang Q
J Cancer Res Ther; 2014 Nov; 10 Suppl():C173-8. PubMed ID: 25450278
[TBL] [Abstract][Full Text] [Related]
10. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
[TBL] [Abstract][Full Text] [Related]
11. Blood-based multiple-microRNA assay displays a better diagnostic performance than single-microRNA assay in the diagnosis of breast tumor.
Xin H; Li X; Yang B; Zhang L; Han Z; Han C
Tumour Biol; 2014 Dec; 35(12):12635-43. PubMed ID: 25213696
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
[TBL] [Abstract][Full Text] [Related]
15. Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis.
Meng QC; Qiu WW; Wen ZQ; Wang HC; Shan ZZ; Yuan Z; Huang XY
Tumori; 2015; 101(2):199-205. PubMed ID: 25838251
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
Shi HB; Yu JX; Yu JX; Feng Z; Zhang C; Li GY; Zhao RN; Yang XB
World J Surg Oncol; 2017 Aug; 15(1):147. PubMed ID: 28774300
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
[TBL] [Abstract][Full Text] [Related]
18. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma.
Gao Y; Zhao H; Lu Y; Li H; Yan G
Tumour Biol; 2014 Nov; 35(11):11041-50. PubMed ID: 25095976
[TBL] [Abstract][Full Text] [Related]
20. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
